Enzo Biochem (ENZ) Looks Good: Stock Jumps 13.3% in Session

Loading...
Loading...

Enzo Biochem, Inc. ENZ was a big mover last session, as the company saw its shares rise above 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 10% in the past one-month time frame.

The company has seen no positive or negative estimate revision in the past 30 days. Also, its Zacks Consensus Estimate remained unchanged over the same timeframe. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Enzo Biochem, Inc. ENZ currently carries a Zacks Rank #3 (Hold).

Enzo Biochem, Inc. Price

 

A better-ranked stock in the Medical – Biomedical and Genetics industry is Cambrex Corporation CBM holding a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Is ENZ going up? Or down? Predict to see what others think:Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report

Enzo Biochem, Inc. ENZ: Free Stock Analysis Report

Cambrex Corporation CBM: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...